Glimniv MV 2mg/500mg/0.2mg Tablet
Marketer
Nivulia Lifesciences Private Limited
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Glimniv MV 2mg/500mg/0.2mg Tablet
Diabexe Trio 2mg/500mg/0.2mg tablets are classified as antidiabetic agents. This combination medication treats type 2 diabetes in adults by managing blood glucose levels. Diabexe Trio should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar readings. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. Remember, this medication complements a comprehensive diabetes management plan incorporating diet, exercise, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. The most frequent adverse effect is hypoglycemia (low blood sugar). Familiarize yourself with hypoglycemia symptoms—sweating, dizziness, headache, and tremors—and appropriate countermeasures. Maintain regular meals and carry readily available glucose sources, such as sugary snacks or juice. Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease to your doctor prior to use. Pregnant or lactating individuals should seek medical counsel before initiating treatment. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.
Uses of Glimniv MV 2mg/500mg/0.2mg Tablet
Managing type 2 diabetes
Major Benefits of Glimniv MV 2mg/500mg/0.2mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimniv MV 2mg/500mg/0.2mg Tablet whole; do not break, crush, or chew it. Administer on an empty stomach.
Common Side effects of Glimniv MV 2mg/500mg/0.2mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glimniv MV 2mg/500mg/0.2mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume the Glimniv MV 2mg/500mg/0.2mg tablet on an empty stomach.
How Glimniv MV 2mg/500mg/0.2mg Tablet works:
Each Glimniv MV 2mg/500mg/0.2mg tablet contains a triple-action blend of antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimniv MV 2mg/500mg/0.2mg tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Using Glimniv MV 2mg/500mg/0.2mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Glimniv MV 2mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Preliminary evidence in humans indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Glimniv MV 2mg/500mg/0.2mg tablets is likely unsafe for individuals with kidney impairment and should be eschewed. Physician consultation is advised. Furthermore, this medication is contraindicated in patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Glimniv MV 2mg/500mg/0.2mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate hepatic dysfunction, a low initial dose is typically recommended; however, it's contraindicated in patients with severe liver disease.
What if you forget to take Glimniv MV 2mg/500mg/0.2mg Tablet :
Should you forget to take a Glimniv MV 2mg/500mg/0.2mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.
Facts to Know About Glimniv MV 2mg/500mg/0.2mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |
3,018 People bought this recently